Sponsored Content
Intercell AG / Intercell announces pediatric approval of its Japanese Encephalitis vaccine in Europe
Press Wire ♦
Published: February 12, 2013; 08:04 ♦ (Vindobona)

Intercell AG / Intercell announces pediatric approval of its Japanese Encephalitis vaccine in Europe

Company Information
Wien (euro adhoc) - Vienna (Austria), February 12, 2013 - Intercell AG (VSE;
"ICLL") announced today that the pediatric indication for IXIARO®, a vaccine to
protect against Japanese Encephalitis (JE),…
or Log In
Fast News Search
ISIN